positive COVID-19
[용어속성] Term
Deep-learning algorithms for the interpretation of chest radiographs to aid in the triage of COVID-19 patients: A multicenter retrospective study
COVID-19 환자 분류에 도움이 되는 흉부 방사선 사진 해석을 위한 딥 러닝 알고리즘: 다기관 후향적 연구
Multicenter Study
[키워드] Accuracy
Adult patients
Algorithm
all the patients
Chain Reaction
Chest
Chest computed tomography
chest CT scan
Chest CT scans
Chest radiography
Clinical efficacy
clinician
Community
comparable
Computed tomography
consolidation
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
COVID-19 patients
COVID-19 pneumonia
demonstrated
diagnose
diagnosed
Diagnosis
diagnostic
Efficacy
Emergency Departments
evaluate
evaluated
Evidence
evidence of
facilitate
FIVE
Formal
ground-glass opacity
infiltration
Interpretation
Isolation
medical staff
multicenter
offer
outcomes
Patient
physician
Pneumonia
polymerase chain
polymerase chain reaction
positive
positive COVID-19
radiologist
Radiologists
reduce
Retrospective study
reverse transcription
reverse transcription polymerase chain reaction
Sensitivity and specificity
significantly
speed
the patient
Treatment
were used
[DOI] 10.1371/journal.pone.0242759 PMC 바로가기 [Article Type] Multicenter Study
[DOI] 10.1371/journal.pone.0242759 PMC 바로가기 [Article Type] Multicenter Study
Atypical presentation of COVID-19; an observational retrospective study
Observational Study
[키워드] age
alcohols
Atypical
clinical presentation
COVID-19
COVID-19 infection
database
diagnosis of COVID-19
died
Dyspnea
evaluate
evaluated
False negative
feature
Final
Glasgow coma scale
Health care worker
healthy
hospital
Infection
Inpatient
Invasive mechanical ventilation
Iran
male
methanol
Patient
PCR
PCRs
polymerase chain
positive
positive COVID-19
presenting symptoms
respiratory symptoms
Result
Retrospective study
signs
Symptom
Symptoms
Tehran
were excluded
[DOI] 10.1186/s12879-020-05617-z PMC 바로가기 [Article Type] Observational Study
[DOI] 10.1186/s12879-020-05617-z PMC 바로가기 [Article Type] Observational Study
SARS-CoV-2 viremia may predict rapid deterioration of COVID-19 patients
SARS-CoV-2 바이러스혈증은 COVID-19 환자의 급속한 악화를 예측할 수 있습니다
Article
[키워드] accompanied
addition
asynchrony
Blood
blood oxygen
clearance
COVID-19
COVID-19 patient
COVID-19 pneumonia
decrease
Deterioration
heart rate
Hypoxemia
indicate
inflammation storm
Injury
lead
Lung CT
marker
multiple organ
multiple organs
nucleic acid
nucleic acid test
oxygen
pandemic
Pneumonia
poor prognosis
positive
positive COVID-19
predict
raised
Rapid
Replication
report
SARS-CoV-2
SARS-CoV-2 nucleic acid
Septic shock
tendency
Viremia
[DOI] 10.1016/j.bjid.2020.08.010 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.bjid.2020.08.010 PMC 바로가기 [Article Type] Article
Radiological Findings of COVID-19 Patients in Italy
Original Contribution
[키워드] analyzed
assist
Chest
China
Clinical finding
Computed tomography
COVID-19
COVID-19 cases
COVID-19 patients
CT scan
database
diagnosing
Diagnosis
diagnostic
Efficacy
evaluated
finding
indicated
initial
Italy
National
outbreak
pandemic
Patient
performed
positive
positive COVID-19
problem
Radiograph
radiologic imaging
radiological
radiological finding
radiology
retrospective
SARS-CoV2
similarity
statistical analysis
Strains
Swab
tested
the disease
Transmission
were used
with COVID-19
X-ray
[DOI] 10.51894/001c.14505 PMC 바로가기 [Article Type] Original Contribution
[DOI] 10.51894/001c.14505 PMC 바로가기 [Article Type] Original Contribution
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 1:1
24 hour
Ability
absence
accompany
activity
Administered
administration
Admission
adverse events
Affect
age
alkaline phosphatase
allergy
ALT
alternative hypothesis
ambient
Analysis
ANC
Anti-inflammatory
anticipated
antipyretics
antivirals
Arm
ARMS
assumed
AST
Baltimore
baseline
benefit
blinded
block
block randomization
Blood
breastfeeding women
Bronchoalveolar lavage
calculated
Care
Cellulose
center
Chest
chest X-ray
childbearing potential
clinical
clinical condition
Clinical course
clinical impact
Clinical improvement
Clinical outcome
clinical status
clinical trial
collected
competing
Compliance
concealed
Concentration
Concomitant
conditions
conducted
congestive heart failure
Contraception
Control
control arm
Conventional
Corticosteroids
COVID-19
COVID-19 disease
COVID-19 infection
COVID-19 pandemic
criteria
criterion
Critical
CT scan
current
Day
Declaration of Helsinki
decrease
defined
detect
direct bilirubin
disease
disorder
dissemination
dose
double-blind
drug
Drug administration
drug-drug interaction
drugs
Duration
ECMO
Efficacy
Efficacy and safety
element
eligible
endosomal pH
Enrollment
ethnic group
evaluate
Evidence
exclusion
expected
exploratory endpoint
extracorporeal membrane oxygenation
Face mask
FDA
Fisher
Good
group
handling
harmonization
hematologic
histocompatibility complex
Hospitalization
Hospitalized
hospitalized patient
Hydroxychloroquine
Hypothesis
ICU
IL-6 levels
Imatinib
immunomodulatory
immunomodulatory drugs
IND
information
Informed consent
inhibitory activity
intensive care
intensive care unit
intention to treat
interfere
International Conference
invasive
Invasive mechanical ventilation
investigational agent
investigator
ITT
Laboratory
Last
limit
limitation
liver
Local
lysosomal sequestration
magnitude
matching placebo
mechanical ventilation
men and women
MHC
mononuclear cell
Mortality
nasal
nasopharyngeal
Nasopharyngeal swab
neutrophil count
New
new oxygen use
non-invasive ventilation
non-rebreather mask
not blinded
null hypothesis
number
objective
off-label
off-label use
Oropharyngeal
outcome
outcomes
oxygen
Oxygenation
P450
packaged
PaO
participant
Participants
Patient
patients
patients with ARDS
patients with COVID-19
PBMCs
performed
Pharmacist
Pharmacy
phase 3 study
Placebo
placebo-controlled
Pneumonia
positive COVID-19
Practice
primary analysis
primary endpoint
principal
progression
proportion
protocol
Psychiatric
Radiographic
random number generator
randomised controlled trial
randomization
Randomized
Randomized controlled trial
receive
receiving
recruitment
Regulatory
renal dysfunction
renal replacement therapy
replication of SARS-CoV-2
required
requiring supplemental oxygen
Respiratory illness
respiratory tract
risk
RT-PCR
Safety
Sample size
sarilumab
SARS-CoV
SARS-CoV-2
secondary endpoint
Seizure
Serious Adverse Events
service
severe disease
severity
significance level
Site
Society
stability
Standard of care
status
stratified
study drug
study enrollment
study outcomes
Study protocol
subject
submitted
supplemental oxygen
Support
Suspension
symptomatic
Tablet
temperature
Test
the patient
the primary endpoint
time
TKI
TKI-induced attenuation of vascular leak
TKI-induced prevention and treatment lung inflammation
Tocilizumab
transcriptomics
Treatment
treatment allocation
treatment arm
treatments for COVID-19
Trial
two-sided
tyrosine kinase inhibitor
uncontrolled
university
unstable angina
vasopressors
ventilator
ventilator free days
viral ABL-1 signalling
website
with COVID-19
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04819-9 PMC 바로가기 [Article Type] Letter
Sociodemographic features and mortality of individuals on haemodialysis treatment who test positive for SARS-CoV-2: A UK Renal Registry data analysis
Research Article
[키워드] 95% CI
Adults
age
Asian
collected data
COVID-19
Data analysis
disease
effort
England
Evidence
feature
General population
Haemodialysis
highest
individual
Mortality
outcomes
Patient
patients with COVID-19
positive
positive COVID-19
PROTECT
registry
retrospective cohort study
risk
risk factor
Support
survival
Treatment
[DOI] 10.1371/journal.pone.0241263 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pone.0241263 PMC 바로가기 [Article Type] Research Article
The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial
COVID-19 환자의 치료 보조제로 커큐민을 함유한 나노 미셀의 임상 효과 및 치료 후 면역 반응 균형 변화: 무작위 대조 시험을 위한 연구 프로토콜의 구조화된 요약
Letter
[키워드] 1:1
accompany
addition
allergy
assigned
balance
Bandar Abbas
bedtime
blind
Blinding
both groups
breakfast
Capsule
change
Characteristics
chronic
chronic obstructive pulmonary disease
clinical
Clinical effect
clinical examination
clinical examinations
clinical symptom
clinical trial
clinical trials
Comorbidities
Comorbidity
company
comparator
Complete
computer
conducted
congestive heart failure
control group
COVID-19
COVID-19 patient
COVID-19 patients
Curcumin
Cytokines
digit
digits
dinner
dissemination
Effectiveness
element
evaluate
evaluated
expected
expression
filtration
filtration rate
FOXP3
gallstone
gastritis
GATA
Gender
Gene Expression
glomerular filtration rate
heart failure
history
IFN-γ
IL-17
IL-4
immune response
immune responses
in both group
inclusion criteria
Inflammatory marker
inflammatory markers
information
Interleukins
intervention group
Iran
kPa
Laboratory
laboratory findings
laboratory technician
laboratory technicians
lactation
less
liver
liver failure
Lymphocytes
number
Nurses
objective
Obstructive
obstructive pulmonary disease
outcome
PaO2
parallel group
participant
Participation
Patient
patients
patients with COVID-19
per day
performed
Peripheral blood
physician
Placebo
placebo group
placebo-controlled
positive COVID-19
post treatment
Pregnancy
protocol
pulmonary disease
random
randomisation
randomised
randomised controlled trial
randomization
Randomized
randomized clinical trial
Randomly
real time PCR
recorded
recruitment
Registered
registry
Regulatory
renal
renal failure
routine standard treatment
Sample size
sealed
selected
serum cytokine
serum cytokines
Serum level
serum parameter
serum parameters
shift
single-center
statisticians
Study protocol
T helper
TGF-β
the placebo group
therapeutic
Treatment
Trial
Trial registration
ventilator
Version
website
written consent
[DOI] 10.1186/s13063-020-04824-y PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04824-y PMC 바로가기 [Article Type] Letter
Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System
Research
[키워드] addition
Adjusted analysis
Adjusting
Admission
age
alcohol
antibody tests
black
Black patient
BMI
body mass index
calculated
Cancer
Characteristics
classification
cohort study
Comorbidities
Comorbidity
coronavirus disease
covariates
COVID-19
COVID-19 hospitalization
COVID-19 infections
death
defined
Department
determine
diagnosed with COVID-19
died
disparity
examined
explained
exposure
Factor
finding
group
health condition
high-risk population
higher risk
Hospitalization
hospitalizations
Hospitalized
Human
ICU
ICU admission
Importance
increased risk
individual
intensive care
Kidney disease
Male sex
measure
Mortality
nasopharynx
Ninth
obesity
objective
Odds ratio
Older age
outcome
outcomes
participant
Patient
PCR
performed
Point
polymerase chain
positive
positive COVID-19
Racial
Randomly
reason
Relevance
Result
retrospective cohort study
revision
risk factor
selected
service
setting
Sex
smoking
Sociodemographic
Sociodemographic characteristics
Sociodemographic factor
statistically significant
Support
System
targeted intervention
tested
treated
type 2 diabete
type 2 diabetes
University of Michigan
white
White patient
White patients
with COVID-19
[DOI] 10.1001/jamanetworkopen.2020.25197 PMC 바로가기 [Article Type] Research
[DOI] 10.1001/jamanetworkopen.2020.25197 PMC 바로가기 [Article Type] Research
Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients
Short Communication
[키워드] added
addition
Admission
age
analyses
Care
caused
Clinical characteristics
Combination
Comorbidities
coronavirus
COVID 19
COVID-19
discharged home
Evidence
Frequency
hospital
Hospitalization
hospitalized COVID-19 patient
Hydroxychloroquine
ICU
IMPROVE
in vitro
in vivo
Infection
intensive care
Ionophore
management
medical record
medication
Mortality
New York City
not differ
outcome
pandemic
Patient
positive COVID-19
Potential
Prophylaxis
protocol
provide
receive
reduction in mortality
remained
Result
retrospective
Sex
therapeutic
therapy
transfer
Ventilation
was collected
were excluded
were recorded
Zinc
zinc sulfate
[DOI] 10.1099/jmm.0.001250 PMC 바로가기 [Article Type] Short Communication
[DOI] 10.1099/jmm.0.001250 PMC 바로가기 [Article Type] Short Communication